How can we accurately measure disease activity during pregnancy in systemic lupus erythematosus? New insights from the BILAG-2004 Pregnancy Index

Sasha Ali^{1

2}, Carmen Garcia^{2

3}, Serena Fasano⁴, Charles Raine⁵, Chris Wincup^{1

5}

Affiliations

¹ Department of Rheumatology, King's College Hospital, London, UK.
² Department of Rheumatology, King's College London, London, UK.
³ Department of Rheumatology, University Hospital of Basurto, Bilbao, Spain.
⁴ Rheumatology Unit, Department of Precision Medicine, University of Campania, "Luigi Vanvitelli", Naples, Italy.
⁵ Department of Rheumatology, Division of Medicine, University College London, London, UK.

Editorial

Sasha Ali et al. Rheumatol Adv Pract. 2023.

. 2023 Feb 16;7(1):rkad024.

doi: 10.1093/rap/rkad024. eCollection 2023.

Sasha Ali^{1

2}, Carmen Garcia^{2

3}, Serena Fasano⁴, Charles Raine⁵, Chris Wincup^{1

5}

¹ Department of Rheumatology, King's College Hospital, London, UK.
² Department of Rheumatology, King's College London, London, UK.
³ Department of Rheumatology, University Hospital of Basurto, Bilbao, Spain.
⁴ Rheumatology Unit, Department of Precision Medicine, University of Campania, "Luigi Vanvitelli", Naples, Italy.
⁵ Department of Rheumatology, Division of Medicine, University College London, London, UK.

Erratum in

Correction to: How can we accurately measure disease activity during pregnancy in systemic lupus erythematosus? New insights from the BILAG-2004 Pregnancy Index.
[No authors listed] [No authors listed] Rheumatol Adv Pract. 2023 Apr 27;7(2):rkad043. doi: 10.1093/rap/rkad043. eCollection 2023. Rheumatol Adv Pract. 2023. PMID: 37122808 Free PMC article.

No abstract available

1. Ntali S, Nikolopoulos D, Pantazi L. et al. Remission or low disease activity at pregnancy onset are linked to improved foetal outcomes in women with systemic lupus erythematosus: results from a prospective observational study. Clin Exp Rheumatol 2022;40:1769–78. - PubMed
1. Tedeschi SK, Guan H, Fine A, Costenbader KH, Bermas B.. Organ-specific systemic lupus erythematosus activity during pregnancy is associated with adverse pregnancy outcomes. Clin Rheumatol 2016;35:1725–32. - PMC - PubMed
1. Kither H, Heazell A, Bruce IN, Tower C, Crocker I.. Adverse pregnancy outcomes and subsequent development of connective tissue disease in the UK: an epidemiological study. BJOG 2020;127:941–9. - PubMed
1. Yee C-S, Khamashta M, Akil M. et al. The BILAG2004-Pregnancy Index is a valid disease activity outcome measure for pregnant SLE patients. Rheumatol Adv Pract 2022;6:rkac081. - PMC - PubMed
1. Kaufman KP, Eudy AM, Harris N, Neil L, Clowse MEB.. Pregnancy outcomes in undifferentiated connective tissue disease compared to systemic lupus erythematosus: a single academic center's experience. Arthritis Care Res 2022;74:1631–9. - PMC - PubMed